HOME >> BIOLOGY >> NEWS
American Chemical Society's Weekly PressPac -- July 25, 2007

mature mouse muscle cells (top) and its transformation into nerve-like cells (bottom) after treatment with neurodazine. (Courtesy of Injae Shin, Yonsei University, Korea.)

DOWNLOAD PDF
http://pubs.acs.org/cgi-bin/sample.cgi/jacsat/asap/pdf/ja072817z.pdf

DOWNLOAD HTML
http://pubs.acs.org/cgi-bin/sample.cgi/jacsat/asap/html/ja072817z.html

CONTACT:
Injae Shin, Ph.D.
Department of Chemistry
Yonsei University
Seoul, Korea
Phone: +82-2-2123-2631
E-mail: injae@yonsei.ac.kr


ARTICLE #2 FOR IMMEDIATE RELEASE

Oil spill clean-up agents threaten coral reefs
Environmental Science & Technology

In a setback for efforts to protect endangered coral reefs from oil spills, researchers in Israel report that oil dispersants the best tool for treating oil spills in tropical areas are significantly more toxic to coral than the oil they are used to clean up. Their study, which urges caution in the use of these materials, is scheduled for the August 1 issue of ACS Environmental Science & Technology, a semi-monthly journal.

Called the rainforests of the sea, coral reefs are an endangered ecosystem and are disappearing at an alarming rate due to numerous threats, including over-fishing, global warming and pollution, particularly oil spills. Besides hosting a rich diversity of marine organisms, these habitats are also potential sources of life-saving medicines and food for humans. Scientists looking for better ways to protect this important habitat have recently focused on the environmental impact of oil dispersants, detergents used break down oil spills into smaller, less harmful droplets.

In the new report, Sh
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
30-Jul-2007


Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
5. American buffalo slaughter fueled by international trade
6. American Chemical Societys Weekly PressPac -- July 18, 2007
7. American Chemical Societys Weekly PressPac -- July 11, 2007
8. Tips from the Journals of the American Society for Microbiology
9. Wiley extends publishing partnership with the American Institute of Chemical Engineers
10. Highlights from the July 2007 Journal of the American Dietetic Association
11. Scientific American launches innovative new version of magazine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Chemical Society Weekly PressPac July

(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: